Connection

VIVEK SUBBIAH to Quinazolines

This is a "connection" page, showing publications VIVEK SUBBIAH has written about Quinazolines.
Connection Strength

0.398
  1. Vandetanib photoinduced cutaneous toxicities. Cutis. 2019 May; 103(5):E24-E29.
    View in: PubMed
    Score: 0.120
  2. Systemic and CNS activity of the RET inhibitor vandetanib combined with the mTOR inhibitor everolimus in KIF5B-RET re-arranged non-small cell lung cancer with brain metastases. Lung Cancer. 2015 Jul; 89(1):76-9.
    View in: PubMed
    Score: 0.091
  3. Photoallergic reaction in a patient receiving vandetanib for metastatic follicular thyroid carcinoma: a case report. BMC Dermatol. 2015 Feb 13; 15:2.
    View in: PubMed
    Score: 0.090
  4. Treatment of patients with advanced neurofibromatosis type 2 with novel molecularly targeted therapies: from bench to bedside. J Clin Oncol. 2012 Feb 10; 30(5):e64-8.
    View in: PubMed
    Score: 0.072
  5. Comprehensive Genomic Profiling of Clinically Advanced Medullary Thyroid Carcinoma. Oncology. 2016; 90(6):339-46.
    View in: PubMed
    Score: 0.025
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.